Navigation Links
Biologist who cloned Dolly the sheep believes therapeutic cloning will gain acceptance

n the United States, it also can be used in embryonic stem cell research or in regenerative medicine, where it is referred to as therapeutic cloning.

In the nuclear-transfer process, the nucleus of a somatic cell, a body cell other than a sperm or egg cell, is removed, as is the nucleus of an egg cell. The nucleus of the somatic cell, which contains the organism's DNA, is then inserted i......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 05/18/07


Page: 1 2 3 4

Related biology technology :

1. TDS believes faster DSL service will suit small businesses
2. Berbee believes acquisition by CDW will make it a national IT player
3. Quintessence Biosciences forms cancer therapeutic advisory board
4. Successful PCR amplification and subcloning of a GC-rich DNA fragment
5. Doyle vetoes cloning ban
6. Separating science fiction from reality in the human cloning debate
7. Wisconsin Senate votes to outlaw cloning; measure still faces veto
8. Amendment on cloning ban rejected; vote on bill set for Wednesday
9. UN committee opposes human cloning
10. Human cloning plans get blessing from British government
11. Public Hearing Held for controversial anti-cloning bills
Post Your Comments:
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3